Nevakar spins off ophthalmic-only company Vyluma

Video

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.

Recent Videos
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Dr. Mark Bullimore investigates myopia in an omnibus model at AAOpt 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr Adam Wenick at EyeCon 2024
Brianna Rhue, OD, FAAO, FSLS, talks myopia management at Vision Expo West 2024
Jack Chapman, MD, talks best candidates for light adjustable lenses.
Mandy Sallach of Johnson & Johnson speaks on initiatives to combat pediatric myopia
Drs Tracy Schroeder Swartz and Clark Chang overview their keratoconus talk at Optometry's Meeting
© 2024 MJH Life Sciences

All rights reserved.